Allergan Braces for Restasis Generic with 1,400 Job Cuts

Allergan plans to cut over 1,000 jobs and eliminate an additional 400 open positions, in an attempt to cut costs in the face of new generic competition for dry-eye treatment, Restasis.

Source: Pharma Manufacturing
More...